[1]Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2): 281-297.[2]郑永霞, 焦炳华. miRNA的生物形成及调控基因表达机制. 生命的化学, 2010, 30(6): 821-826.Zheng Y X, Jiao B H. Biogenesis of microRNA and mechanism of the regulation of gene expression. Chemistry of Life, 2010, 30(6): 821-826. (in Chinese)[3]王星果, 郁建锋, 顾志良. microRNA在肌肉发育中的功能研究进展. 生命科学, 2010, 22(2): 133-138.Wang X G, Yu J F, Gu Z L. Function of microRNA in muscle development. Chinese Bulletin of Life Sciences, 2010, 22(2): 133-138. (in Chinese)[4]McCarthy J J, Esser K A. MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. Journal of Applied Physiology, 2007, 102(1): 306-313.[5]Chen J F, Mandel E M, Thomson J M, Wu Q, Callis T E, Hammond S M, Conlon F L, Wang D Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics, 2006, 38(2): 228-233.[6]Huang M B, Xu H, Xie S J, Zhou H, Qu L H. Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis. PLoS One, 2011, 6(12): e29173.[7]Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang M L, Segnalini P, Gu Y, Dalton N D, Elia L, Latronico M V, Hoydal M, Autore C, Russo M A, Dorn G W, Ellingsen O, Ruiz-Lozano P, Peterson K L, Croce C M, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 2007, 13(5): 613-618.[8]Belevych A E, Sansom S E, Terentyeva R, Ho H T, Nishijima Y, Martin M M, Jindal H K, Rochira J A, Kunitomo Y, Abdellatif M, Carnes C A, Elton T S, Gyorke S, Terentyev D. MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS One, 2011, 6(12): e28324.[9]Tao J, Wu D, Xu B, Qian W, Li P, Lu Q, Yin C, Zhang W. microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor. Oncology Reports, 2012, 27(6): 1967-1975.[10]项茹, 吴正升, 张晴, 徐晓春, 吴强. miR-133a在乳腺癌组织中的表达及其临床意义. 安徽医科大学学报, 2011, 46(2): 109-112.Xiang R, Wu Z S, Zhang Q, Xu X C, Wu Q. Expression of miR-133a in breast carcinoma and its significance. Acta Universitatis Medicinalis Anhui, 2011, 46(2): 109-112. (in Chinese)[11]谢海涛. miR-133a在结肠癌组织中的表达. 广东医学, 2012, 33(15): 2242-2243.Xie H T. Expression of miR-133a in colon carcinoma. Guangdong Medical Journal, 2012, 33(15): 2242-2243. (in Chinese)[12]Ambrosini G, Adida C, Altieri D C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nature Medicine, 1997, 3(8): 917-921.[13]Dallaglio K, Marconi A, Pincelli C. Survivin: a dual player in healthy and diseased skin. The Journal of Investigative Dermatology, 2012, 132(1): 18-27.[14]Li F, Ambrosini G, Chu E Y, Plescia J, Tognin S, Marchisio P C, Altieri D C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature, 1998, 396(6711): 580-584.[15]Li F, Ackermann E J, Bennett C F, Rothermel A L, Plescia J, Tognin S, Villa A, Marchisio P C, Altieri D C. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nature Cell Biology, 1999, 1(8): 461-466.[16]Barrett R M, Colnaghi R, Wheatley S P. Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro. Cell Cycle, 2011, 10(3): 538-548.[17]Wang X G, Yu J F, Zhang Y, Gong D Q, Gu Z L. Identification and characterization of microRNA from chicken adipose tissue and skeletal muscle. Poultry Science, 2012, 91(1): 139-149.[18]Li T, Wu R, Zhang Y, Zhu D. A systematic analysis of the skeletal muscle miRNA transcriptome of chicken varieties with divergent skeletal muscle growth identifies novel miRNAs and differentially expressed miRNAs. BMC Genomics, 2011, 12: 186.[19]Lewis B P, Shih I H, Jones-Rhoades M W, Bartel D P, Burge C B. Prediction of mammalian microRNA targets. Cell, 2003, 115(7): 787-798.[20]Lewis B P, Burge C B, Bartel D P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120(1): 15-20.[21]Chen C, Ridzon D A, Broomer A J, Zhou Z, Lee D H, Nguyen J T, Barbisin M, Xu N L, Mahuvakar V R, Andersen M R, Lao K Q, Livak K J, Guegler K J. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research, 2005, 33(20): e179.[22]Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 2001, 25(4): 402-408.[23]Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty K E, Lawson N D. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature, 2010, 464(7292): 1196-1200.[24]Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 2005, 436(7048): 214-220.[25]Zhao Y, Ransom J F, Li A, Vedantham V, von Drehle M, Muth A N, Tsuchihashi T, McManus M T, Schwartz R J, Srivastava D. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 2007, 129(2): 303-317.[26]Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nature Cell Biology, 2006, 8(3): 278-284.[27]Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, Mandelboim M, Mandelboim O. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nature Immunology, 2008, 9(9): 1065-1073. |